Clinical Trial Update: IC-8 Apthera IOL New Enrollment Post Approval Study

View source ↗

Summary

Post-approval study for the IC-8 Apthera intraocular lens is enrolling new participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Posterior Capsule Opacification
• Presbyopia

Drugs mentioned

• IC-8 Apthera IOL

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Cataract, Presbyopia | Status: RECRUITING